» Articles » PMID: 3470778

Amyloid of Neurofibrillary Tangles of Guamanian Parkinsonism-dementia and Alzheimer Disease Share Identical Amino Acid Sequence

Overview
Specialty Science
Date 1987 Apr 1
PMID 3470778
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of abundant intraneuronal amyloid in the form of neurofibrillary tangles (NFT) in the brains of Guamanian parkinsonism-dementia patients and the absence of extraneuronal amyloid in the form of vascular amyloid deposits or senile plaques permit the purification of NFT without contamination with extraneuronal amyloid. Thus, we have isolated and determined the amino acid sequence of the polypeptide subunit of the amyloid fibrils of these NFT and describe their ultrastructure. The NFT, which consist of single and paired helical filaments, similar to those of Alzheimer disease, and occasionally triple helical filaments, are composed of multimeric aggregates of a polypeptide of 42 amino acids (A4 protein). The relative molecular mass of the subunit protein, 4.0-4.5 kDa, is the same as the molecular mass of the amyloid of NFT, of the amyloid plaque cores, and of vascular amyloid deposits in Alzheimer disease and Down syndrome; the sequence of 15 amino acid residues at the N-terminus of the amyloid fibrils in the NFT of Guamanian parkinsonism-dementia is identical to that of the amyloid of NFT, amyloid plaque cores, and cerebrovascular deposits in Alzheimer disease and Down syndrome. Furthermore, the heterogeneity, or variation in polypeptide length, of the N-terminus of the amyloid of Guamanian parkinsonism-dementia is the same as in Alzheimer disease and Down syndrome. Our observations indicate that the brain amyloids of these diseases have a common subunit protein, which would also indicate a common pathogenesis.

Citing Articles

The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease Progression.

Franco R, Garrigos C, Lillo J, Rivas-Santisteban R Cells. 2024; 13(15.

PMID: 39120318 PMC: 11311351. DOI: 10.3390/cells13151288.


Models of environmentally induced neurological disease: epidemiology and etiology of amyotrophic lateral sclerosis and parkinsonism-dementia in the Western Pacific.

Garruto R, Yanagihara R, Gajdusek D Environ Geochem Health. 2013; 12(1-2):137-51.

PMID: 24202580 DOI: 10.1007/BF01734063.


Amyloids: friend or foe?.

Hammer N, Wang X, McGuffie B, Chapman M J Alzheimers Dis. 2008; 13(4):407-19.

PMID: 18487849 PMC: 2674399. DOI: 10.3233/jad-2008-13406.


Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease.

Huse J, Doms R Mol Neurobiol. 2001; 22(1-3):81-98.

PMID: 11414282 DOI: 10.1385/MN:22:1-3:081.


Neurofibrillary tangles of Guamanian amyotrophic lateral sclerosis, parkinsonism-dementia and neurologically normal Guamanians contain a 4- to 4.5-kilodalton protein which is immunoreactive to anti-amyloid beta/A4-protein antibodies.

Guiroy D, MELLINI M, Miyazaki M, Hilbich C, Safar J, Garruto R Acta Neuropathol. 1993; 86(3):265-74.

PMID: 8213085 DOI: 10.1007/BF00304141.


References
1.
Wisniewski H, Narang H, Terry R . Neurofibrillary tangles of paired helical filaments. J Neurol Sci. 1976; 27(2):173-81. DOI: 10.1016/0022-510x(76)90059-9. View

2.
Kidd M . ALZHEIMER'S DISEASE--AN ELECTRON MICROSCOPICAL STUDY. Brain. 1964; 87:307-20. DOI: 10.1093/brain/87.2.307. View

3.
Glenner G, Wong C . Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984; 120(3):885-90. DOI: 10.1016/s0006-291x(84)80190-4. View

4.
Merz P, Rohwer R, Kascsak R, Wisniewski H, Somerville R, Gibbs Jr C . Infection-specific particle from the unconventional slow virus diseases. Science. 1984; 225(4660):437-40. DOI: 10.1126/science.6377496. View

5.
Glenner G, Wong C . Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun. 1984; 122(3):1131-5. DOI: 10.1016/0006-291x(84)91209-9. View